A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to assess the efficacy of QL1074 compared with placebo in achieving renal response after 52 weeks of therapy in subjects with Active Lupus Nephritis.
Epistemonikos ID: d0742031e7560eca2ec1ae4177437b96d0416048
First added on: Mar 22, 2025